Bonnet MMB, Gabillard D, Domoua SK, Muzoora C, Messou E, et al.
2023-03-08 • Clinical Infectious Diseases
2023-03-08 • Clinical Infectious Diseases
BACKGROUND In people with HIV (PWH), the WHO-recommended tuberculosis four-symptom screen (W4SS) targeting those who need molecular rapid test may be suboptimal. We assessed the perf...
Castillo-Mancilla JR, Morrow M, Boum Y II, Byakwaga H, Haberer JE, et al.
2018-01-16 • Journal of Acquired Immune Deficiency Syndromes (1999)
2018-01-16 • Journal of Acquired Immune Deficiency Syndromes (1999)
Residual systemic inflammation persists despite suppressive antiretroviral therapy (ART) and is associated with non-AIDS clinical outcomes. We aimed to evaluate the association between A...
Bebell LM, Kembabazi A, Musinguzi N, Martin JN, Hunt PW, et al.
2021-12-01 • SSM - Mental Health
2021-12-01 • SSM - Mental Health
Depression affects over 40% of people with HIV (PHIV) in low- and middle-income countries, and over half of PHIV report HIV-related internalized stigma. However, few longitudinal studies...
2022-06-29 • TB Research Dissemination Workshop, Epicentre Uganda
2022-06-29 • TB Research Dissemination Workshop, Epicentre Uganda
BACKGROUND In regions with high burdens of tuberculosis and human immunodeficiency virus (HIV), many HIV-infected adults begin antiretroviral therapy (ART) when they are already seve...
Blanc FX, Badje AD, Bonnet MMB, Gabillard D, Messou E, et al.
2020-06-18 • New England Journal of Medicine
2020-06-18 • New England Journal of Medicine
BACKGROUND In regions with high burdens of tuberculosis and human immunodeficiency virus (HIV), many HIV-infected adults begin antiretroviral therapy (ART) when they are already seve...
Ariza-Vioque E, Ello F, Andriamamonjisoa H, Machault V, González-Martín J, et al.
2022-06-29 • Infectious Diseases and Therapy
2022-06-29 • Infectious Diseases and Therapy
Tuberculous meningitis (TBM) is the most severe and disabling form of tuberculosis (TB), with at least 100,000 cases per year and a mortality rate of up to 50% in individuals co-infected...
Byakwaga H, Huang Y, Muzoora C, Kembabazi A, Weiser SD, et al.
2014-02-28 • Journal of Infectious Diseases
2014-02-28 • Journal of Infectious Diseases
Human immunodeficiency virus (HIV) infection-induced indoleamine 2,3-dioxygenase-1 (IDO) expression in activated monocytes and dendritic cells catabolizes tryptophan to kynurenine and ot...
Musinguzi N, Castillo-Mancilla JR, Morrow M, Byakwaga H, Mawhinney S, et al.
2019-12-01 • Journal of Acquired Immune Deficiency Syndromes (JAIDS)
2019-12-01 • Journal of Acquired Immune Deficiency Syndromes (JAIDS)
BACKGROUND Residual systemic inflammation, which is associated with non-AIDS clinical outcomes, may persist despite viral suppression. We assessed the effect of antiretroviral therap...
Loyse A, Burry J, Cohn J, Ford NP, Chiller T, et al.
2018-10-18 • Lancet Infectious Diseases
2018-10-18 • Lancet Infectious Diseases
In 2018, WHO issued guidelines for the diagnosis, prevention, and management of HIV-related cryptococcal disease. Two strategies are recommended to reduce the high mortality associated w...
Rao PS, Moore CC, Mbonde AA, Nuwagira E, Orikiriza P, et al.
2021-06-18 • Antibiotics
2021-06-18 • Antibiotics
Critical illness from tuberculosis (TB) bloodstream infection results in a high case fatality rate for people living with human immunodeficiency virus (HIV). Critical illness can lead to...
